Costs and outcomes of atypical antipsychotics for the treatment of acute schizophrenia

被引：0
|
作者：
Leeuwenkamp, O. [1 ]
Morlock, R. [2 ]
Bell, C. F. [3 ]
Brogan, A. [4 ]
Mauskopf, J. [4 ]
机构：
[1] NV Organon, NL-5340 BH Oss, Netherlands
[2] Pfizer Inc, Ann Arbor, MI USA
[3] GlaxoSmithKline Inc, Memphis, TN USA
[4] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65094-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [41] The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia
    Awad, A. George
    Voruganti, Lakshmi N. P.
    CNS DRUGS, 2013, 27 (08) : 625 - 636
  • [42] Inpatient treatment of schizophrenia:: A study of two leading atypical antipsychotics
    Laux, G
    König, W
    Jones, M
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 38 - 38
  • [43] Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
    Faries, Douglas
    Ascher-Svanum, Haya
    Zhu, Baojin
    Correll, Christoph
    Kane, John
    BMC PSYCHIATRY, 2005, 5 (1)
  • [44] Outpatient treatment initiation with atypical antipsychotics: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Edgell, ET
    Frewer, P
    Wright, P
    Novick, D
    Haro, JM
    McKendrick, J
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A20 - A20
  • [45] Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in Medicaid
    Seabury, Seth A.
    Goldman, Dana P.
    Kalsekar, Iftekhar
    Sheehan, John J.
    Laubmeier, Kimberly
    Lakdawalla, Darius N.
    AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (02): : E52 - E60
  • [46] Atypical antipsychotics not associated with improved hospitalisation outcomes compared with typical antipsychotics in people with schizophrenia in real practice
    Taylor, David
    EVIDENCE-BASED MENTAL HEALTH, 2013, 16 (02) : 36 - 36
  • [47] Selection of atypical antipsychotics for the management of schizophrenia
    Sprague, DA
    Loewen, PS
    Raymond, CB
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 313 - 319
  • [48] Schizophrenia therapy: beyond atypical antipsychotics
    Snyder, Eric M.
    Murphy, Melanie R.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 471 - 472
  • [49] Schizophrenia, weight gain and atypical antipsychotics
    Brown, S
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 191 - 192
  • [50] Schizophrenia therapy: beyond atypical antipsychotics
    Eric M. Snyder
    Melanie R. Murphy
    Nature Reviews Drug Discovery, 2008, 7 : 471 - 472
12345